The Female Health Company to Present at 7th Annual Singular Research Conference

     The Female Health Company to Present at 7th Annual Singular Research
                                  Conference

PR Newswire

CHICAGO, Oct. 30, 2012

CHICAGO, Oct. 30, 2012 /PRNewswire/ --The Female Health Company (NASDAQ-CM:
FHCO), which manufactures and markets the FC2 Female Condom, today announced
that it will be presenting at the Singular Research Seventh Annual "Best of
the Uncovereds" Conference on Thursday, November 1, 2012, in Los Angeles,
California.

(Logo: http://photos.prnewswire.com/prnh/20120712/MM39764LOGO)

The Company's Chief Executive Officer, O.B. Parrish, and Chief Financial
Officer, Donna Felch, are scheduled to present at 1:30 p.m. Pacific Time (4:30
p.m. Eastern Time). A live webcast of this presentation will be available on
the Internet at http://www.singularresearch.com.

During the remainder of the day, management will meet with investors during a
series of one-on-one breakout meetings. Interested parties should contact Bill
Jones at Singular (267-987-2082) to schedule a meeting. The conference is
being held at the Luxe Sunset Boulevard Hotel in Los Angeles.

About Singular Research
Singular Research aims to be the most trusted supplier of independent
single-source research on small-to-micro cap companies for
small-to-medium-sized money managers. Singular will provide quarterly updates
for 30 to 60 companies and make recommendations. Singular's goal is to provide
initiation reports and quarterly updates for approximately 50
micro-to-small-cap companies. Singular's independent analysts have no
financial interest in the stocks they cover. Analysts are compensated based on
the accuracy of their research calls, not through trading commissions or
potential deal flow. Singular's coverage list performance since inception in
August 2004 is a positive 153.59% through December 2011, compared with a
positive 13.88% for the S&P 500. For more information about Singular Research,
visit http://www.singular-research.com. For more information about the
conference, please contact:

Robert Maltbie, CFA
Singular Research
818-222-6915
robert@singularresearch.com

About The Female Health Company
The Female Health Company, based in Chicago, Illinois, manufactures and
markets the FC2 Female Condom® (FC2), which is available in the U.S. and
approximately 138 other countries. The Company owns certain worldwide rights
to the FC2 Female Condom®, including patents that have been issued in the
U.S., the European Union, Canada, Australia, South Africa, Japan, The People's
Republic of China, Spain, Mexico, Greece, Turkey and by the African Regional
Intellectual Property Organization (ARIPO), which includes Botswana, The
Gambia, Ghana, Kenya, Lesotho, Malawi, Mozambique, Namibia, Sierra Leone,
Somalia, Sudan, Swaziland, Uganda, United Republic of Tanzania, Zambia and
Zimbabwe. FC2 patent applications are pending in various countries. The FC2
Female Condom® is the only available FDA-approved product controlled by a
woman that offers dual protection against sexually transmitted diseases,
including HIV/AIDS, and unintended pregnancy. The World Health Organization
(WHO) has cleared FC2 for purchase by U.N. agencies.

"Safe Harbor" statement under the Private Securities Litigation Reform Act of
1995:

The statements in this release which are not historical facts are
forward-looking statements based upon the Company's current plans and
strategies, and reflect the Company's current assessment of the risks and
uncertainties related to its business, including such things as product demand
and market acceptance; the economic and business environment and the impact of
government pressures; currency risks; capacity; efficiency and supply
constraints; and other risks detailed in the Company's press releases,
shareholder communications and Securities and Exchange Commission filings.
Actual events affecting the Company and the impact of such events on the
Company's operations may vary from this currently anticipated.

For more information about the Female Health Company visit the Company's
website at http://www.femalehealth.com and http://www.femalecondom.org. If you
would like to be added to the Company's e-mail alert list, please send an
e-mail to FHCInvestor@femalehealthcompany.com.

SOURCE The Female Health Company

Website: http://www.femalehealth.com
Contact: William R. Gargiulo, Jr., +1-231-526-1244, or Donna Felch, CFO,
+1-312-595-9123